PharmAthene (PIP) engaged in the development and commercialization of medical countermeasures against biological and chemical weapons, is currently trading at a price of $2.35 with 52-week high $4.96 and 52-week low of $1.28, it has approximately Market Cap of $113M. The company had revenues in... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]